Fiduciary Management Inc. WI lifted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 7.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,488,335 shares of the company’s stock after buying an additional 167,990 shares during the quarter. Henry Schein comprises about 1.6% of Fiduciary Management Inc. WI’s holdings, making the stock its 23rd biggest holding. Fiduciary Management Inc. WI owned 2.00% of Henry Schein worth $172,193,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also modified their holdings of HSIC. Forum Financial Management LP purchased a new stake in Henry Schein in the fourth quarter valued at approximately $221,000. Farringdon Capital Ltd. acquired a new position in shares of Henry Schein in the 4th quarter valued at $423,000. Ontario Teachers Pension Plan Board purchased a new stake in Henry Schein in the 4th quarter valued at $289,000. Guggenheim Capital LLC boosted its stake in Henry Schein by 2.5% during the 4th quarter. Guggenheim Capital LLC now owns 6,428 shares of the company’s stock worth $445,000 after purchasing an additional 159 shares during the period. Finally, Canada Post Corp Registered Pension Plan purchased a new position in Henry Schein during the 4th quarter worth $95,000. Institutional investors and hedge funds own 96.62% of the company’s stock.
Insider Activity at Henry Schein
In other news, Director Philip A. Laskawy sold 2,604 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares of the company’s stock, valued at $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.
Analyst Ratings Changes
View Our Latest Stock Report on HSIC
Henry Schein Price Performance
Shares of NASDAQ:HSIC opened at $64.73 on Friday. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The firm has a market capitalization of $7.93 billion, a price-to-earnings ratio of 26.64, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. The business’s 50 day simple moving average is $70.41 and its 200-day simple moving average is $71.96. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.
Henry Schein (NASDAQ:HSIC – Get Free Report) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period last year, the company posted $0.66 EPS. As a group, equities analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
See Also
- Five stocks we like better than Henry Schein
- How to find penny stocks to invest and tradeĀ
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- How to Invest in Biotech Stocks
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- Trading Stocks: RSI and Why it’s Useful
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.